Your browser doesn't support javascript.
SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network.
Araujo, Danielle Bastos; Machado, Rafael Rahal Guaragna; Amgarten, Deyvid Emanuel; Malta, Fernanda de Mello; de Araujo, Gabriel Guarany; Monteiro, Cairo Oliveira; Candido, Erika Donizetti; Soares, Camila Pereira; de Menezes, Fernando Gatti; Pires, Ana Carolina Cornachioni; Santana, Rúbia Anita Ferraz; Viana, Amanda de Oliveira; Dorlass, Erick; Thomazelli, Luciano; Ferreira, Luis Carlos de Sousa; Botosso, Viviane Fongaro; Carvalho, Cristiane Rodrigues Guzzo; Oliveira, Danielle Bruna Leal; Pinho, João Renato Rebello; Durigon, Edison Luiz.
  • Araujo DB; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • Machado RRG; Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.
  • Amgarten DE; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • Malta FM; Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.
  • de Araujo GG; Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.
  • Monteiro CO; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • Candido ED; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • Soares CP; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • de Menezes FG; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • Pires ACC; Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.
  • Santana RAF; Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.
  • Viana AO; Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.
  • Dorlass E; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • Thomazelli L; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • Ferreira LCS; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • Botosso VF; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • Carvalho CRG; Instituto Butantã, Centro de Inovação e Desenvolvimento, Laboratório de Virologia, São Paulo, SP, Brasil.
  • Oliveira DBL; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • Pinho JRR; Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Microbiologia, São Paulo, SP, Brasil.
  • Durigon EL; Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.
Mem Inst Oswaldo Cruz ; 115: e200342, 2020.
Article in English | MEDLINE | ID: covidwho-895110
ABSTRACT

BACKGROUND:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was confirmed in Brazil in February 2020, the first cases were followed by an increase in the number of cases throughout the country, resulting in an important public health crisis that requires fast and coordinated responses.

OBJECTIVES:

The objective of this work is to describe the isolation and propagation properties of SARS-CoV-2 isolates from the first confirmed cases of coronavirus disease 2019 (COVID-19) in Brazil.

METHODS:

After diagnosis in patients that returned from Italy to the São Paulo city in late February by RT-PCR, SARS-CoV-2 isolates were obtained in cell cultures and characterised by full genome sequencing, electron microscopy and in vitro replication properties.

FINDINGS:

The virus isolate was recovered from nasopharyngeal specimen, propagated in Vero cells (E6, CCL-81 and hSLAM), with clear cytopathic effects, and characterised by full genome sequencing, electron microscopy and in vitro replication properties. Virus stocks - viable (titre 2.11 × 106 TCID50/mL, titre 1.5 × 106 PFUs/mL) and inactivated from isolate SARS.CoV2/SP02.2020.HIAE.Br were prepared and set available to the public health authorities and the scientific community in Brazil and abroad. MAIN

CONCLUSION:

We believe that the protocols for virus growth and studies here described and the distribution initiative may constitute a viable model for other developing countries, not only to help a rapid effective pandemic response, but also to facilitate and support basic scientific research.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus Limits: Animals / Humans Country/Region as subject: South America / Brazil Language: English Journal: Mem Inst Oswaldo Cruz Year: 2020 Document Type: Article Affiliation country: 0074-02760200342

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus Limits: Animals / Humans Country/Region as subject: South America / Brazil Language: English Journal: Mem Inst Oswaldo Cruz Year: 2020 Document Type: Article Affiliation country: 0074-02760200342